Navigation Links
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Date:6/12/2008

Lilly Gains Access to Transdermal PTH Program for Osteoporosis

INDIANAPOLIS, Ind. and LOD, Israel, June 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and TransPharma Medical Ltd. today announced that the two companies have entered into a licensing and development agreement related to TransPharma's ViaDerm-hPTH (1-34) product for the treatment of osteoporosis. The product, which is administered transdermally using TransPharma's proprietary technology, is currently in Phase II clinical testing.

Under the terms of the agreement, Lilly will obtain exclusive worldwide rights to TransPharma's ViaDerm-hPTH (1-34) product and will also gain non-exclusive access to TransPharma's ViaDerm drug delivery system. TransPharma will receive a $35 million upfront payment, and may also receive development and sales milestones, as well as royalties on sales if a transdermal PTH product is successfully commercialized. TransPharma and Lilly will both fund and participate in Phase II clinical development activities. Thereafter, Lilly will be responsible for further development activities and the potential commercialization of any transdermal PTH products. Other terms of the deal were not disclosed.

The transaction is expected to become effective in either June or July of 2008, contingent upon clearance under the Hart-Scott-Rodino Anti-Trust Improvements Act. At closing, Lilly would expect a $0.02 per share charge to earnings for acquired in-process research and development.

"This agreement expands the scope of our osteoporosis program with a novel, patient-centered approach that builds upon our success with Evista and Forteo," commented Dr. Gwen Krivi, vice president of Lilly Research Labs and global brand developm
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 MedSolutions ( www.medsolutions.com ... services, today commended two new studies highlighting the ... and other diagnostic imaging tests. ,, "When ... diagnosis and treatment," said Gregg Allen, M.D., chief ... offer more compelling evidence that stricter quality control ...
(Date:12/16/2009)... Texas, Dec. 16 Wound Management ... rapidly growing provider of specialty medical products, ... subsidiary is moving toward productization of its ... company currently anticipates products to be introduced ... estimated to be a multi-billion dollar international ...
(Date:12/16/2009)... A new application developed by American ... of specialty pharmaceuticals has increased health plan staff ... reducing costs. ,, AIM, a leading diagnostic imaging ... clients representing over 35 million consumers and an ... WLP ), adapted the successful clinical and technology ...
Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4Older problem drinkers use more alcohol than do their younger counterparts 61819 1Older problem drinkers use more alcohol than do their younger counterparts 61819 2From toxic dust and algae to ill winds from Africa 10839 1From toxic dust and algae to ill winds from Africa 10839 2From toxic dust and algae to ill winds from Africa 10839 3From toxic dust and algae to ill winds from Africa 10839 4From toxic dust and algae to ill winds from Africa 10839 5Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 1Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 2Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 3
... -- for Lung Cancer Diagnosis and, Identification of Tumor Origin in Patients With Cancer ... ... Types With High Sensitivity and, Specificity and Could Revolutionize Diagnosis and Treatment ... Accuracy Exceeding 90% and ...
... Novel Approach to Blood ... Pressure ... innovator in the discovery and development of novel small,molecule therapeutics, ... showed statistically significant,blood pressure reductions in a Phase 2a study ...
Other Medicine Technology:Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8
(Date:12/16/2009)... 16 As a result of C3: Colorectal ... peer reviewed cancer research program is included in the ... This new cancer research program will research cancers, like ... prostate, lung and ovarian cancer research programs run by ... ,, The $15 million in funding for this ...
(Date:12/16/2009)... deadly, attack is long-term goal, researchers say , , ... a tool to predict whether a patient will suffer ... stroke. , "This is an important new tool because ... stroke soon after a first stroke are more likely ... of Massachusetts General Hospital and Harvard Medical School, said ...
(Date:12/16/2009)... a role in reducing inflammation in the lungs , , ... that plays a role in inflammation seems to protect ... adults who smoke. , Researchers also found that adult ... a lower risk of developing chronic obstructive pulmonary disease ... , "The gene seems to be protective of the ...
(Date:12/16/2009)... advance that could help ease health and environmental concerns ... of technology for changing the behavior of nanoparticles in ... the environment. Their study was published in ACS, journal ... from the UK Centre for Ecology and Hydrology and ... production of nanoparticles particles less than 1/1000th the ...
(Date:12/16/2009)... acids commonly found in fatty fish and algae ... published by the American Psychological Association. The finding ... in people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit ... the nervous system. , The study, reported ... more evidence that fish is brain food. The ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2
... A study comparing the safety, effectiveness and reliability of LASIK ... two types of laser eye// surgery. ,The study, ... published in the December 2006 issue of the American Journal ... of the safety and efficacy of both types of laser ...
... suggests that lithium and other drugs that inhibit a ... in treating Alzheimer's disease// because too high a dose ... ,Lithium is currently in clinical trials for treating Alzheimer's. ... inhibitors for the disease because these drugs are relatively ...
... potential flu pandemic showed that nearly 62 million people worldwide, ... their life. , ,The figures seem to toe ... out nearly 20 million people in a single sweep. Researchers ... of Queensland studied the data gathered from 27 countries to ...
... cases of measles were reported from across the U.S of which ... A 17 year old girl, who had travelled to// Romania sans ... The highly contagious infection characterised by typical rashes ,and fever ... had interacted with her upon her return to the U.S after ...
... says it works, but how? University of Oregon researchers ... test subjects watched films of// others building objects with ... 20 issue of the Journal of Neuroscience, researchers, using ... watches someone else perform a task with the intention ...
... approached last year, Soraya Kohanzadeh, 30, Muir Beach, CA, ... hope and expecting to live a shortened life// dependent ... because her “anti-donor” antibody levels were so high, her ... perhaps ever. However, thanks to a specialized type of ...
Other Medicine News:Health News:Study Compares LASIK and LASEK Eye Surgery 2Health News:High Doses of Lithium-Like Drugs May Impair Neuronal Function 2Health News:Missed Vaccination Caused Largest Measles Outbreak in U.S in 2005 2Health News:Watching With Intent to Repeat Ignites Key Learning Area of Brain 2Health News:Therapy Modulates Highly Sensitized Immune System to Let Mother Give Kidney to Daughter 2Health News:Therapy Modulates Highly Sensitized Immune System to Let Mother Give Kidney to Daughter 3Health News:Therapy Modulates Highly Sensitized Immune System to Let Mother Give Kidney to Daughter 4
... The Rubicon Filter System is an ... removes much of the debris that may ... Filter System comprises several components. The first ... is a capture catheter. Other ancillary components ...
... is a simulator for intraocular surgery. The ... surgeon the feeling that he is experiencing ... surgeon uses instruments that feel and function ... through the EYESI microscope is similar to ...
One inch disposable patch electrode uses a specially formulated adhesive solid gel. Reusable lead wire with snap connector provides economic benefits. Ideal for sleep studies where leg movement or EK...
... Made with elastic fabric, these head ... you need to begin testing. Each Electro-Cap ... to the International 10-20 System. When you ... you are using with your head cap ...
Medicine Products: